Abstract Purpose: To evaluate the potential role and cellular mechanism of the CXCR4 antagonist (N15P) derived from the N-terminal of viral macrophage inflammatory protein-II (vMIP-II
INTRODUCTION
Apoptosis of uninfected bystander cells is a key element of HIV pathogenesis and believed to be the driving force behind the selective depletion of CD4 + T cells leading to immunodeficiency. In this regard, inhibition of uninfected cells death is therefore considered to prevent or delay the onset of AIDS.
Several HIV encoded proteins have been implicated in the process of HIV-1 induced uninfected CD4 + T cells apoptosis, such as gp120 [1] , tat [2] , the protease [3] , vpr [4] and nef [5] . Recent evidence suggests that nef is found in abundance in the sera of HIV-infected individuals and induce the apoptosis of uninfected CD4 + T by interacting with CXCR4 surface receptors [6] [7] [8] . But, the molecular basis of how this phenomenon is triggered in uninfected CD4 + T cells is not completely understood. Previous studies demonstrated that FOXO3a pathway was involved in the survival and maintenance of memory CD4 + T-cells [9] , memory B cells [10] , macrophages [11] during HIV infection. Thus, we speculate that the FOXO3a signal pathway might have a possible role in nef-induced bystander apoptosis. Furthermore, a better understanding of how viral proteins interact with or hijack and alter host cell metabolism might provide important insights for understanding of AIDS pathogenesis.
Viral macrophage inflammatory protein-II (vMIP-II), encoded by human herpesvirus-8, has garnered interest because of its ability to bind to multiple chemokine receptors, including CCR5 and CXCR4 [12] . Based on our previously published work on vMIP-II [13] , we synthesized a novel and small molecule selective CXCR4 antagonist N15P (LGASWHRPDKCCLGY) derived from the N-terminal of vMIP-II [14] . In this study, we evaluated the inhibitory effects of N15P on nef-induced uninfected CD4 + T cells apoptosis and the role of FOXO3a signal pathway. These results indicate that N15P has therapeutic potential for uninfected CD4 + T cells apoptosis during HIV infection.
EXPERIMENTAL

Reagents and materials
Anti-phospho-FOXO3a (Ser   253   ) and antiFOXO3a were purchased from Cell Signaling Technology (USA). Anti-β-actin was from Santa Cruz (La Jolla, CA). HIV-1 Nef was from ABcam (USA). The radiolabelling of Nef and the synthesis of N15P were entrusted to the Shanghai YaoQiang Bio-Tech Co, Ltd, China (the final product was at least 95 % pure). All the inhibitors were dissolved in dimethyl sulfoxide (DMSO) (Sigma, USA) with the final concentration not exceeding 0.1 %.
Cells and culture conditions
Jurkat cells (Chinese Academy of Sciences, China) were maintained in RPMI 1640 medium (Invitrogen, USA) supplemented with 10 % fetal bovine serum, streptomycin (100 U/mL), penicillin (100 U/mL), L-glutamine (2 mM), and HEPES-buffered saline solution (30 μM). Peripheral blood was drawn from healthy volunteers (18 -25 years old). PBMCs were isolated from blood samples by Ficoll-Histopaque density gradient centrifugation and cultured in RPMI 1640 medium (Invitrogen, USA) supplemented with 10 % fetal bovine serum (Sigma, USA) and 1 μg/ml phytohemagglutinin (Sigma, USA). Cell viability was determined by trypan blue dye exclusion assay from an optimal suspension of 1 × 10 6 cells/ml. In accordance with ethical standards, the healthy volunteers were properly informed of the study and signed an agreement authorizing the test.
Competitive binding of N15P against Nef
Radioligand binding assay was performed as described previously [15] . Briefly, 1 mg wheat germ agglutinin-coated SPA beads (Amersham Pharmacia Biotech, USA) in 100 μL of binding assay buffer were prepared in a 96-well microtiter plate. N15P was dissolved in 100 % DMSO solution and 1 μl of that solution was added to each well, and then cells (1 × 10 6 cells, 50 μL) were also transferred to wells. Reactions were started by adding 50 μL of 100 pM 125 I-nef at room temperature. One hour later, radioactivity was counted. In all experiments, each data point was assayed in duplicate. Subsequent data analyses were carried out using the program GraphPad Prism 5 (GraphPad, San Diego, CA, USA)
TUNEL staining
Freshly isolated PBMCs (1 × 10 6 cells) and Jurkat (1 × 10 6 cells) were cultured and treated with various concentrations of Nef or together with different concentrations of N15P for 24 -48 h and then the percent cell mortality was measured by the TUNEL assay using Rcho Apoptosis Kit. Apoptotic cells were then assessed as the percentage of TUNEL positive cells per 100 cells in each slide using a light microscope. The data were expressed as the average of triplicates (± SD).
Western blotting
The extraction and isolation of nuclear and cytoplasmic protein were performed according to the nuclear and cytoplasmic protein extraction kit (Beyotime, China) and the concentration of protein was measured using enhanced BCA protein assay kit (Beyotime, China). For western blotting, 30 μg of total protein was separated by 12 % SDS-PAGE in a Tris/HCl buffer system for 90 min at 90 V, transferred onto PVDF membranes (Bio-Rad, USA), and incubated with rabbit anti-FOXO3a (1:1000) or anti-phosphoFOXO3a (Ser   253 ). Mouse anti-rabbit IgG (1:5 000) was used as second antibody. Membranes were washed with TBS-T and incubated in enhanced chemiluminescence detection reagents (Amersham, Sweden) to visualize the proteins of interest. Densitometric analysis was performed using the Gel-Pro Application (version 4.0.0.4).
The effect of siRNA on Jurkat cells and PBMCs
FOXO3a suppression was accomplished using FoxO3a siRNA I (Cell Signaling Technology, USA) and Control siRNA (Unconjugated). SiRNAs (100 nM) were transfected into exponentially growing Jurkat cells and PBMCs with siRNA transfection reagent (Santa Cruz Biotechnology, USA), according to the manufacturer's protocols. After 72 h of cell exposure to siRNAs, parallel siRNA-treated cells were analyzed for the presence of apoptosis by TUNEL staining.
Statistical analysis
Data were expressed as mean values ± standard deviation (SD), and the statistical significance between testing and control groups was analyzed with GraphPad Prism 5.0. When two groups were compared, the unpaired Student's ttest was used. When multiple groups were evaluated, one-way ANOVA was used. p < 0.05 was considered to be statistically significant.
RESULTS
Extracellular soluble HIV-1 Nef-mediated apoptosis of bystander CD4 + T cells
Evidences have shown that the level of soluble nef that circulates in HIV-1-infected individuals was 0-10 ng/ml [16] . So, we first examined the apoptosis effect induced by extracellular soluble HIV-1 nef in vitro, and observed that Nef resulted in significant apoptosis in a dose-and timedependent manner in Jurkat cells. Since Jurkat cells are immortalized lymphocytic cells, we further investigated the apoptotic effects of extracellular HIV-1 Nef on primary PBMCs. Our study showed that extracellular soluble Nef protein induced apoptosis in human PBMCs in a dose and time dependent manner, which was consistent with the results in Jurkat cells (Fig 1) .
N15P inhibited the apoptosis induced by HIV-1 extracellular soluble Nef
The interaction of 125 I-nef with Jurkat cells was inhibited by N15P in a dose-dependent manner, with IC 50 value of 0.3516 ng/ml (Fig 2A) . Following this we examined the effect of N15P on the extracellular soluble HIV-1 Nef-induced apoptosis. The apoptotic activity of extracellular Nef protein on Jurkat and human PBMCs were suppressed after pretreatment with N15P, which was in a time-and dose-dependent manner ( Fig  2B) .
Critical involvement of FOXO3a signaling in bystander apoptosis induced by Nef
On treating the cells with Nef, the phosphorylation level of FOXO3a in Jurkat cells and human PBMCs was decreased in timedependent manner, and FOXO3a was predominantly localized in the nucleus (Fig 3A, B and E). When Jurkat cells were pretreated with 0.5 -2.5 ng/ml N15P for 4 h, and then given 5 ng/ml Nef, which is the middle level of soluble Nef that circulates in HIV-1-infected individuals, we found that N15P up-regulated the phosphoFOXO3a and FOXO3a was lesser localized in the nucleus (fig 3C, D and F) . Moreover, we further silenced the transcriptional active form of FOXO3a, and the results indicated that FoxO3a siRNA led to a significant reduction in apoptosis (Fig 3G) . ) treated with Nef and N15P, 1 = control, 2 = 5 ng/ml Nef, 3 = 5 ng/ml Nef + 0.5 ng/ml N15P, 4 = 5 ng/ml Nef + 1.0 ng/ml N15P, 5 = 5 ng/ml Nef + 1.5 ng/ml N15P, 6 = 5ng/ml Nef + 2.5 ng/ml N15P; (E, F) Densitometric analysis of pFoxo3a/tFoxo3a; the percentage of Jurkat cells (G) and PBMCs (H) apoptosis by silencing the transcriptional active form of FOXO3a; Note: nef = 5 ng/ml nef, SiRNA = SiRNA FOXO3a + 5 ng/ml nef, ConSiRNA = ConSiRNA FOXO3a + 5 ng/ml nef. *p < 0.05 vs the 5 ng/ml Nef group; #p < 0.05 vs control group
DISCUSSION
The G-protein coupled receptor CXCR4 is a coreceptor for HIV-1 infection and is involved in the process of HIV-encoded proteins-induced uninfected CD4 + T cells apoptosis, such as gp120 and nef. The diverse role of the SDF-1/CXCR4 axis in the pathogenesis of HIV has established CXCR4 as a promising therapeutic target [17] . The earliest efforts to find CXCR4 antagonists focused mainly on peptide derivatives, the future perspective on the development of CXCR4 antagonists is the low molecular CXCR4 antagonists [18] . Therefore, N15P was modified by structurally matching, downsizing, and reduction of peptide character in an attempt to develop a new low-molecular weight CXCR4 antagonist that would show remarkable inhibitory activity against entry of HIV into cells.
The extracellular HIV-1 nef protein is synthesized early during the initial viral infection and could contribute to the depletion of uninfected CD4 + T lymphocytes by directly interacting with CXCR4 [6, 7] . In this study, we report that the 15 amino acid peptide (N15P) derived from the N-terminal of vMIP-II inhibits the apoptosis of CD4 + T lymphocytes induced by extracellular HIV-1 Nef protein in vitro. Dose-response and time course assays revealed that N15P significantly reduced the apoptosis of cells induced by Nef protein in both Jurkat and human PBMCs. The explanation for this inhibition is that the antagonist N15P physically blocks the Nef-induced apoptosis through competitive binding to CXCR4.
Evidences have shown that a low level of Nef could cause continued, albeit slower, depletion of T cells [7] , but little is known about the nef-CXCR4 downstream signaling pathways and how they contribute to disease progression. FoxO3a is a member of the FoxO subfamily of forkhead (fox) transcription factors, and the induction of FOXO3a results in the activation of the apoptotic intrinsic (via Bim) and extrinsic (via FasL and TRAIL) pathways [19] . In this present study, the results have shown that treatment of Jurkat cells and PBMCs with Nef protein resulted in the accumulation of FOXO3a in the nucleus and low level of p-FOXO3a.
Pretreatment of Jurkat cells with N15P resulted in activation of p-FOXO3a, suggesting that N15P caused an enhancement of phosphorylated FOXO3a levels, which lead to the FOXO3a nuclear export. When endogenous FOXO3a was knocked down in cells by RNAi, the percentage of apoptosis reduced suggesting that FOXO3a has a pivotal role in Nef-induced apoptosis. It indicates that FOXO3a appears to be a critical factor regulating Nef-induced lymphocytes apoptosis [20] . In addition, pretreatment Jurkat cells with the N15P increased FoxO3a phosphorylation levels and FoxO3a nuclear export, which consequently decreased the apoptosis of Jurkat cells.
Apoptosis is controlled by a variety of cell signals, which may exhibit a substantial crosstalk between each other. In this present study, the apoptosis induced by the extracellular soluble HIV-1 Nef was not fully abolished by FOXO3a siRNA. So, there may be other signal pathways involved in Nef-induced apoptosis and FOXO3a mechanism may not be the only factor involved in the maintenance of Jurkat and PBMCs survival in response to Nef protein. Hence, it will be important to determine whether polymorphisms along the FOXO3a pathway are responsible for Nef-induced bystander apoptosis and more research work should be devoted to unravel the mechanisms of induction of apoptosis by Nef.
CONCLUSION
N15P significantly impedes the rate and levels of apoptosis induced by extracellular soluble HIV-1 Nef, and therefore can reduce virus-associated pathogenesis. The activation of FOXO3a phosphorylation is at least in part responsible for the HIV-1 extracellular soluble Nef-mediated death of the uninfected cell. More importantly, othe findings provide new insight into the mechanism of the extracellular soluble HIV-1 Nef induced apoptosis. However, more insight is needed into the molecular mechanisms involved in the apoptosis induced by Nef in vitro and in vivo. Further studies along these lines are currently ongoing.
